KELLY STRATEGIC CRISPR & GENE EDITING TECHNOLOGY ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.38 USD | -1.60% |
|
-2.45% | -25.75% |
Composition of Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
|---|---|---|---|---|---|---|
| 550.8 USD | -1.32% | -1.15% | +3.77% | 11.69% | ||
| 23.19 USD | +1.22% | -3.98% | -23.94% | 11.15% | ||
| 55.38 USD | -2.21% | -7.08% | -11.53% | 8.55% | ||
| 23.98 USD | -3.46% | +4.08% | -11.90% | 8.03% | ||
| 1.68 USD | +3.70% | -2.33% | -70.68% | 6.97% | ||
| 2.72 USD | +10.12% | +2.64% | -19.05% | 4.87% | ||
| 4.74 USD | -1.46% | -5.95% | -53.21% | 4.83% | ||
| 169 USD | -1.26% | -1.82% | +9.05% | 4.81% | ||
| 5.33 USD | +5.02% | -13.33% | -39.84% | 4.71% | ||
| 4.76 USD | -5.18% | -7.21% | -65.85% | 4.13% | ||
| 96.08 CHF | +0.67% | +2.18% | +13.16% | 3.79% | ||
| 0.3986 USD | -5.86% | -11.52% | -26.63% | 3.66% | ||
| 2.44 USD | +4.27% | 0.00% | -23.99% | 3.54% | ||
| 130.8 USD | -1.72% | -1.45% | -5.92% | 2.57% | ||
| 41.51 USD | -2.33% | +1.15% | -19.10% | 2.37% | ||
| 3.76 USD | +4.44% | 0.00% | -11.94% | 2.23% | ||
| 90.31 EUR | +0.50% | +3.07% | +0.61% | 2.20% | ||
| 106.5 USD | +0.74% | -1.65% | -23.54% | 1.77% | ||
| 472.5 USD | -0.31% | +0.24% | +16.13% | 1.71% | ||
| 1,051 USD | -1.71% | +0.62% | +19.65% | 1.62% | ||
| 228.7 USD | +1.90% | +1.39% | -11.61% | 0.65% | ||
Description
| US48817R7061 | |
|---|---|
| Total Expense Ratio | 0.78% |
| Asset Class | Actions |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Strategic CRISPR & Gene Editing Technology Index NR - USD |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Replication Model | |
| Date of creation |
12/01/2022
|
| Geographical Focus |
AuM evolution ( 31/10/2023 )
| AuM (EUR) | 2 M€ |
|---|---|
| AuM 1M | 2 M€ |
| AuM 3 months | 2 M€ |
| AuM 6 months | 2 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- XDNA ETF
- Components Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
